Table 6.
Methylphenidate Dosage (mg/kg, bid) |
||||
---|---|---|---|---|
Control group (0) n=9 | Low-dose group (2.5) n=9 | High-dose group (12.5) n=10 | ||
Lesion | Prevalence, % | Prevalence, % | Prevalence, % | P |
Myelin figure/body in the sarcoplasm | 100 | 100 | 90 | NE |
Membrane accumulation in the sarcoplasm | 100 | 89 | 80 | 0.75 |
Edema in the sarcoplasm | 78 | 78 | 70 | 0.90 |
Dilution of the sarcoplasmic reticulum | 89 | 89 | 80 | 0.81 |
Increased lipid droplets | 33 | 33 | 40 | 0.94 |
Lipofuscin bodies | 78 | 78 | 90 | 0.70 |
Hypercomplex folding in the nucleus | 0 | 11 | 10 | NE |
Myelin figures in the extracellular space | 56 | 33 | 40 | 0.71 |
Mitochondria in the extracellular space | 44 | 44 | 60 | 0.79 |
Cellular infiltration of mononuclear cell, focal** | 33 | 33 | 10 | 0.48 |
Necrosis, focal** | 11 | 0 | 0 | NE |
NE, not estimatable. Unless otherwise noted, all data are from transmission electron microscopy.
Prevalence was 100% across all dosage groups for degenerative mitochondria, myelin figure mitochondria, increased mitochondria, and dysmorphic mitochondria. Probability values for statistical differences in percentages between dosage groups were calculated with exact permutation tests.
Type I error rate (α) =0.01.
Light microscopy